Xi M, et al. - In patients with esophageal adenocarcinoma (EAC) after neoadjuvant chemoradiotherapy (CRT), researchers determined recurrence risk stratification and its impact on postoperative surveillance. Six hundred one patients with EAC who had neoadjuvant CRT followed by esophagectomy were involved in the investigation between 1998 and 2014. Based on pathologic response and pretreatment clinical stage, they proposed a recurrence risk stratification system for EAC patients. The study findings suggested that risk-based postoperative surveillance strategies could be developed for different risk categories.